SCHEMBL7020179

SCHEMBL7020179

CC(C[CH]C(=O)N[C@@H](Cc1ccccc1)C(=O)Nc1cccnc1)C(N)=O

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP2 P08253 2/20 0.51
MMP1 P03956 3/20 0.50
PKM P14618 1/20 0.49
RAB9A P51151 1/20 0.47
FPR2 P25090 1/20 0.46
HTT P42858 1/20 0.45
MMP3 P08254 1/20 0.45
MMP7 P09237 1/20 0.45
SMN1; SMN2 Q16637 3/20 0.42
ALOX15 P16050 1/20 0.41
CTSD P07339 1/20 0.41
MMP12 P39900 1/20 0.41
PSMB11 A5LHX3 1/20 0.41
PSMA7 O14818 1/20 0.41
PSMB1 P20618 1/20 0.41
PSMA1 P25786 1/20 0.41
PSMA2 P25787 1/20 0.41
PSMA3 P25788 1/20 0.41
PSMA4 P25789 1/20 0.41
PSMB8 P28062 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7344259 0.91 MEN1 (0.52) MMP2MMP1RAB9AHTTSMN1; SMN2
SCHEMBL7029937 0.89 SMN1; SMN2 (0.47) MMP2MMP1RAB9AHTTMMP3
SCHEMBL7030404 0.81 SMN1; SMN2 (0.44) RAB9AFPR2HTTSMN1; SMN2ALOX15
SCHEMBL6840142 0.81 FCER2 (0.49) MMP2MMP1RAB9AMMP3MMP7
SCHEMBL7025425 0.80 HSPA5 (0.63) MMP2PKMMMP3MMP7
SCHEMBL7342497 0.77 MMP9 (0.48) RAB9ASMN1; SMN2
SCHEMBL7345065 0.76 HDAC8 (0.56) MMP1RAB9AFPR2SMN1; SMN2
SCHEMBL7336531 0.76 NPC1 (0.54) RAB9ASMN1; SMN2
SCHEMBL7342788 0.76 NPC1 (0.54) RAB9ASMN1; SMN2
SCHEMBL7348738 0.76 NPC1 (0.54) RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0865339-B1 METALLOPROTEINASE INHIBITORS BRITISH BIOTECH PHARM (GB) 2003-01-22 EP claimed
EP-0865339-A1 METALLOPROTEINASE INHIBITORS BRITISH BIOTECH PHARMACEUTICALS LIMITED (GB) 1998-09-23 EP claimed
WO-1997003783-A9 METALLOPROTEINASE INHIBITORS 1997-04-03 WO claimed
WO-1997003783-A1 METALLOPROTEINASE INHIBITORS BRITISH BIOTECH PHARMACEUTICALS LIMITED (GB) 1997-02-06 WO claimed
EP-0865339-B1 METALLOPROTEINASE INHIBITORS BRITISH BIOTECH PHARM (GB) 2003-01-22 EP disclosed
US-6103739-A BONE RESORPTION; ANTIINFLAMMATORY AGENTS, SKIN DISORDERS; ANTITUMOR-CARCINOGENIC AND METASTASES AGENTS; ANGIOGENESIS INHIBITORS; ANTIARRITHIC AGENTS; RHEUMATOID DISEASES; OSTEOARTHRITIS, PERIODONTITIS, GINGIVITIS AND CORNEAL ULCERS BRITISH BIOTECH PHARMACEUTICALS LIMITED (GB) 2000-08-15 US disclosed
EP-0865339-A1 METALLOPROTEINASE INHIBITORS BRITISH BIOTECH PHARMACEUTICALS LIMITED (GB) 1998-09-23 EP disclosed
WO-1997003783-A9 METALLOPROTEINASE INHIBITORS 1997-04-03 WO disclosed
WO-1997003783-A1 METALLOPROTEINASE INHIBITORS BRITISH BIOTECH PHARMACEUTICALS LIMITED (GB) 1997-02-06 WO disclosed